Cargando…
Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis
The gut is a well-established route of infection and target for viral damage by SARS-CoV-2. This is supported by the clinical observation that about half of COVID-19 patients exhibit gastrointestinal (GI) complications. We aimed to investigate whether the analysis of plasma could provide insight int...
Autores principales: | Prasad, Ram, Patton, Michael John, Floyd, Jason Levi., Fortmann, Seth, DuPont, Mariana, Harbour, Angela, Wright, Justin, Lamendella, Regina, Stevens, Bruce R., Oudit, Gavin Y., Grant, Maria B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409329/ https://www.ncbi.nlm.nih.gov/pubmed/36012406 http://dx.doi.org/10.3390/ijms23169141 |
Ejemplares similares
-
Microbial Signatures in The Rodent Eyes With Retinal Dysfunction and Diabetic Retinopathy
por: Prasad, Ram, et al.
Publicado: (2022) -
The Importance of a Healthy Microbiome in Pregnancy and Infancy and Microbiota Treatment to Reverse Dysbiosis for Improved Health
por: DuPont, Herbert L., et al.
Publicado: (2023) -
Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation
por: DuPont, Herbert L., et al.
Publicado: (2022) -
Dysbiosis of the microbiome in gastric carcinogenesis
por: Castaño-Rodríguez, Natalia, et al.
Publicado: (2017) -
Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021)